BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38200174)

  • 1. Clever placozoans.
    Domingues V
    Nat Ecol Evol; 2024 Jan; 8(1):2. PubMed ID: 38200174
    [No Abstract]   [Full Text] [Related]  

  • 2. Field biology of placozoans (Trichoplax): distribution, diversity, biotic interactions.
    Pearse VB; Voigt O
    Integr Comp Biol; 2007 Nov; 47(5):677-92. PubMed ID: 21669749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence in the field of a long-term, year-round, stable population of placozoans.
    Maruyama YK
    Biol Bull; 2004 Feb; 206(1):55-60. PubMed ID: 14977730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The most primitive metazoan animals, the placozoans, show high sensitivity to increasing ocean temperatures and acidities.
    Schleicherová D; Dulias K; Osigus HJ; Paknia O; Hadrys H; Schierwater B
    Ecol Evol; 2017 Feb; 7(3):895-904. PubMed ID: 28168026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I-IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1
    Ålgars A; Kemppinen L; Fair-Mäkelä R; Mustonen H; Haglund C; Jalkanen S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium.
    Salmi M; Koskinen K; Henttinen T; Elima K; Jalkanen S
    Blood; 2004 Dec; 104(13):3849-57. PubMed ID: 15297319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools to prevent cancer growth and spread: a 'Clever' approach.
    Hollmén M; Figueiredo CR; Jalkanen S
    Br J Cancer; 2020 Aug; 123(4):501-509. PubMed ID: 32595212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clever-1 positive macrophages in breast cancer.
    Mutka M; Virtakoivu R; Joensuu K; Hollmén M; Heikkilä P
    Breast Cancer Res Treat; 2022 Oct; 195(3):237-248. PubMed ID: 35917053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers.
    Hollmén M; Maksimow M; Rannikko JH; Karvonen MK; Vainio M; Jalkanen S; Jalkanen M; Mandelin J
    Mol Cancer Ther; 2022 Jul; 21(7):1207-1218. PubMed ID: 35500016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8
    Viitala M; Virtakoivu R; Tadayon S; Rannikko J; Jalkanen S; Hollmén M
    Clin Cancer Res; 2019 Jun; 25(11):3289-3303. PubMed ID: 30755440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.
    Dunkel J; Viitala M; Karikoski M; Rantakari P; Virtakoivu R; Elima K; Hollmén M; Jalkanen S; Salmi M
    Front Immunol; 2018; 9():2257. PubMed ID: 30349531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clever-1/stabilin-1 controls cancer growth and metastasis.
    Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
    Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic expression of CLEVER-1 in breast cancer and its relationship with lymph node metastasis.
    Ammar A; Mohammed RA; Salmi M; Pepper M; Paish EC; Ellis IO; Martin SG
    Anal Cell Pathol (Amst); 2011; 34(1-2):67-78. PubMed ID: 21483103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages.
    Palani S; Maksimow M; Miiluniemi M; Auvinen K; Jalkanen S; Salmi M
    Eur J Immunol; 2011 Jul; 41(7):2052-63. PubMed ID: 21480214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where is my mind? How sponges and placozoans may have lost neural cell types.
    Ryan JF; Chiodin M
    Philos Trans R Soc Lond B Biol Sci; 2015 Dec; 370(1684):. PubMed ID: 26554046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placozoan affinity for Dickinsonia and the evolution of late Proterozoic metazoan feeding modes.
    Sperling EA; Vinther J
    Evol Dev; 2010; 12(2):201-9. PubMed ID: 20433459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster Randomized Trial: Sun Protection Intervention 'Clever in Sun and Shade for Preschools'-Effectiveness and Dissemination.
    Seidel N; Fieber V; Breitbart EW; Bornhäuser M; Stölzel F
    Children (Basel); 2021 Jul; 8(8):. PubMed ID: 34438542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Habitat Suitability and Ecological Niche Separation in the Phylum Placozoa.
    Paknia O; Schierwater B
    PLoS One; 2015; 10(11):e0140162. PubMed ID: 26580806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1.
    Tadayon S; Dunkel J; Takeda A; Eichin D; Virtakoivu R; Elima K; Jalkanen S; Hollmén M
    Front Immunol; 2021; 12():602122. PubMed ID: 33746947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry.
    Scierka LE; Jelani QU; Smolderen KG; Gosch K; Spertus JA; Mena-Hurtado C; Jones P; Dreyer RP
    Contemp Clin Trials; 2022 Jan; 112():106624. PubMed ID: 34793986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.